Genetic Analysis of HLA- and HPA-Typing in Idiopathic (Autoimmune) Thrombocytopenic Purpura Patients Treated with Cepharanthin

References

• Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980; 56: 329–343
   PubMed Web of Science ®Google Scholar
• McMillan R. Chronic idiopathic thrombocytopenic purpura. N. Engl. J. Med. 1981; 304: 1135–1147
   PubMed Web of Science ®Google Scholar
• Arnott J., Horsewood P., Kelton J. G. Measurement of platelet-associated IgG in animal models of immune and nonimmune thrombocytopenia. Blood 1987; 69: 1294–1299
   PubMed Web of Science ®Google Scholar
• Oyaizu N., Yasumizu R., Miyama-Inaba M., Nomura S., Yoshida H., Miyawaki S., et al. (NZWxBXSB) F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J. Exp. Med. 1988; 167: 2017–2022
   PubMed Web of Science ®Google Scholar
• von dem Borne A. E.G.Kr., van Leeuwen E. F., von Riesz L. E., van Boxtel C. J., Engelfriet C. P. Neonatal alloimmune thrombocytopenia: Detection and characterization of the responsible antibodies by the platelet immunofluorescence test. Blood 1981; 57: 649–656
   PubMed Web of Science ®Google Scholar
• von dem Borne A. E.G.Kr., Ouwehand W. H. Immunology of platelet disorders. Bailliere's Clin. Haematol. 1989; 2: 749–781
   PubMedGoogle Scholar
• McFarland J. G., Aster R. H., Bussel J. B., Gianopoulos J. G., Derbes R. S., Newman P. J. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991; 78: 2276–2282
   PubMed Web of Science ®Google Scholar
• Dreyfus M., Kaplan C., Verdy E., Schlegel N., Durand-Zaleski I., Tchernia G., et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997; 89: 4402–4406
   PubMed Web of Science ®Google Scholar
• Tomiyama Y., Kurata Y., Shihata Y., Honda S., Furubayashi T., Mizutani H., et al. Immunochemical characterization of an autoantigen on platelet glycoprotein IIb in chronic ITP: comparison with the Baka alloantigen. Brit. J. Haematol. 1989; 71: 77–83
   PubMed Web of Science ®Google Scholar
• Taaning E., Killmann S. A. A case of ‘auto-immune thrombocytopenic purpura’ serologically similar to post-transfusion purpura. Vox Sang 1992; 62: 108–112
   PubMed Web of Science ®Google Scholar
• Saiki R. K., Bugawan T. L., Horn G. T., Mullis K. B., Erlich H A. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163–166
   PubMed Web of Science ®Google Scholar
• Mullis K. B., Fallona F. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987; 155: 335–350
   PubMed Web of Science ®Google Scholar
• Ahn Y. S., Harrington W. J. Treatment of idiopathic thrombocytopenic purpura. Ann. Rev. Med. 1977; 28: 299–309
   PubMed Web of Science ®Google Scholar
• Ahn Y. S., Harrington W. J., Simon S. R., Mylvaganam R., Pall L. M., So A. G. Danazol for treatment of idiopathic thrombocytopenic purpura. N. Engl. J. Med. 1983; 308: 1396–1399
   PubMed Web of Science ®Google Scholar
• Berchtold P., McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 14: 2309–2317
   Google Scholar
• Imbach P., Barandun S., D'Appuzo V., Baumgartner C., Hirt A., Morell A., et al. High dose intravenous gamma globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; ii: 1228–1231
   Google Scholar
• Utsumi K., Miyahara M., Sugiyama K., Sasaki J. Effect of biscoclaurine alkaloid on the cell membrane related to membrane fluidity. Acta Histochem. Cytochem. 1976; 9: 59–68
   Web of Science ®Google Scholar
• Miyahara M., Aono K., Queseda J. S., Shimono K., Baba Y., Yamashita S. Protection by cepharanchin of the mitochondrial function from damage induced by snake venom, phospholipase A2, lysolecthin and lead. Cell Struct. Funct. 1978; 3: 61–65
   Web of Science ®Google Scholar
• Shiraishi N., Arima T., Aono K., Inouye B., Morimoto Y., Utsumi K. Inhibition of biscoclaurine alkaloid of lipid peroxidation in biological membranes. Physiol. Chem. Physics 1980; 12: 299–305
   PubMedGoogle Scholar
• Aono K., Shiraishi N., Arita T., Inouye B., Nakazawa T., Utsumi K. Changes in mitochondrial function by lipid peroxidation and their inhibition by hiscoclaurine alkaloid. Physiol. Chem. Physics 1981; 13: 137–144
   PubMedGoogle Scholar
• Nagatsuka S., Nakazawa T. Effects membrane-stabilizing agents, cholesterol and cepharanthin, on radiation-induced lipid peroxidation and permeability in liposomes. Biochem. Biophys. Acta 1982; 691: 171–177
   Google Scholar
• Miyahara M., Okimatsu E., Mikasa H., Terada S., Kodama H., Utsumi K. Improvement of the anoxia-induced mitochondrial dysfunction by membrane modulation. Arch. Biochem. Biophys. 1984; 233: 139–150
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Katayama T., Ochiai S., Yoshida M., Kaito K., Matsuoka H., et al. High-dose cepharanthin therapy for idiopathic thrombocytopenic purpura. Rinsho-Ketsueki 1992; 33: 405–407
   PubMedGoogle Scholar
• Nakayama S., Matsushita A., Ichiba S., Nagai K. Clinical evaluation of cepharanthin for chronic idiopathic thrombocytopenic purpura. Rinsho-Ketsueki 1992; 33: 408–409
   PubMedGoogle Scholar
• Nomura S., Yanahu M., Miyake T., Miyazaki Y., Kawakatsu T., Kido H., et al. Effect of cepharanthin and cytocharasin D on platelet internalization of anti-glycoprotein IIb/IIIa antibodies. Autoimmunity 1994; 18: 23–29
   PubMed Web of Science ®Google Scholar
• Ota M., Seki T., Fukushima H., Tsuji K., Inoko H. HLA DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39: 187–202
   PubMedGoogle Scholar
• Helmerhorst F. N., Nijenhuis L. E., De G. G., Lange P. M., van den Berg-Loonen Jansen M. F.M., von dem Borhe A. E.G.K., et al. HLA antigens in idiopathic thrombocytopenic purpura. Tissue Antigens 1982; 20: 372–379
   PubMedGoogle Scholar
• Gratama J. W., D'Amaro J., De Koning J., DenOttolander G. J. The HLA-system in immune thrombocytopenic purpura: its relation to the outcome of therapy. Brit. J. Haematol. 1984; 56: 287–293
   PubMed Web of Science ®Google Scholar
• Porges A., Bussel J., Kimberky R., Schukman I., Pollak M., Pandez J., et al. Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes. Tissue Antigens 1985; 26: 132–137
   PubMedGoogle Scholar
• Nakao S., Takamatsu H., Chuhjo T., Ueda M., Shiobara S., Matsuda T., et al. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood 1994; 84: 4257–4261
   PubMed Web of Science ®Google Scholar
• Nimer S. D., Ireland P., Meshkinpour A., Frane M. An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 1994; 84: 923–927
   PubMed Web of Science ®Google Scholar
• Nomura S., Matsuzaki T., Ozaki Y., Yamaoka M., Yoshimura C., Katsura K, et al. Clinical significance of HLA-DRBI*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood 1998; 91: 3616–3622
   PubMed Web of Science ®Google Scholar
• McMillan R., Longmire R. L., Tavassoli M., Armstrong S., Yelenosky R. In vitro platelet phagocytosis by LTP splenic leukocytes in idiopathic thrombocytopenic purpura. N. Enql. J. Med. 1974; 290: 249–251
   PubMed Web of Science ®Google Scholar
• Ruiz P., Gomez F., King M., Lopez R., Darby C., Schreiber A. D. In vivo glucocorticoid modulation of guinca pig splenic macrophage Fc gamma receptors. J. Clin. Invest. 1991; 88: 149–157
   PubMed Web of Science ®Google Scholar
• McMillan R., Longmire R. L., Yelenosky R. The effect of corticosteroids on human IgG synthesis. J. Immunol. 1976; 116: 1592–1595
   PubMed Web of Science ®Google Scholar
• Saito N., Takemori N., Hirai K., Onodera R., Watanabe S., Kohgo Y. High-dose biococlaurine alkalois together with predonisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura. Am. J. Hematol. 1996; 51: 173–174
   PubMedGoogle Scholar
• Mueller-Eckhardt C. Platelet antigens and antibodies and their clinical implications. Biotest Bulletin 1997; 5: 529–538
   Google Scholar
• Kunicki T. J., Newman P. J. The molecular immunology of platelet proteins. Blood 1992; 80: 1386–1404
   PubMed Web of Science ®Google Scholar
• Taaning E., Antonsen H., Petersen S., Svejgaard A., Thomsen M. HLA antigens and maternal antibodies in alloimmune neonatal thrombocytopenia. Tissue Antigens 1983; 21: 351–359
   PubMedGoogle Scholar
• Mueller-Eckhardt C., Grubert A., Weisheit M., Mueller-Eckhardt G., Kiefel V., Kroll H., et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; i: 363–366
   Google Scholar
• McFarland J. G., Frenzke M., Aster R. H. Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia. Transfusion 1989; 29: 128–133
   PubMed Web of Science ®Google Scholar
• Weiss E. J., Bray P. F., Tayback M., Schulman S. P., Kicker T. S., Becker L. C., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 1996; 334: 1090–1094
   PubMed Web of Science ®Google Scholar
• Sperr W. R., Huber K., Roden M., Janisiw M., Lang T., Graf S., et al. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central europeans. Thromb. Res. 1998; 90: 117–123
   PubMed Web of Science ®Google Scholar
• Gonzalez-Conejero R., Lozano M. L., Rivera J., Corral J., Iniesta J. A., Moraleda J. M., et al. Polymorphisms of platelet membrane glycoprotein Ib α associated with arterial thrombotic disease. Blood 1998; 92: 2771–2776
   PubMed Web of Science ®Google Scholar
• Woods V. L., Oh E. H., Mason D., McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984; 63: 368–375
   PubMed Web of Science ®Google Scholar
• Beardsley D. S., Spiegel J. E., Jacobs M. M., Handin R. I., Lux S. E. Platelet membrane glycoprotein IIIa contains target antigens that bind antiplatelet antibodies in immune thrombocytopenias. J. Clin. Invest. 1984; 74: 1701–1707
   PubMed Web of Science ®Google Scholar
• McMillan R., Tani P., Millard F., Berchtold P., Renshaw L., Woods V. L. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040–1045
   PubMed Web of Science ®Google Scholar
• Mueller-Ekhardt C., Kiefel V., Kroll H., Mueller-Ekhardt G. HLA-DRw6, a new immune response marker for immuninization against the platelet alloantigen Bra. Vox Sang 1989; 57: 90–91
   PubMed Web of Science ®Google Scholar
• Decary F., L'Abbe D., Tremblay L., Chartrand P. The immune response to the HPA-la antigen: association with HLA-DRw52a. Transfus. Med. 1991; 1: 55–62
   PubMedGoogle Scholar